{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:50:58Z","timestamp":1789051858041,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004374","name":"Chongqing Medical University","doi-asserted-by":"publisher","award":["W0183"],"award-info":[{"award-number":["W0183"]}],"id":[{"id":"10.13039\/501100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004374","name":"Chongqing Medical University","doi-asserted-by":"publisher","award":["BYKY-DS2023001"],"award-info":[{"award-number":["BYKY-DS2023001"]}],"id":[{"id":"10.13039\/501100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004374","name":"Chongqing Medical University","doi-asserted-by":"publisher","award":["BYKY-DS2024001"],"award-info":[{"award-number":["BYKY-DS2024001"]}],"id":[{"id":"10.13039\/501100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing Municipality","doi-asserted-by":"publisher","award":["CSTB2022NSCQ-MSX0105"],"award-info":[{"award-number":["CSTB2022NSCQ-MSX0105"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.intimp.2025.115830","type":"journal-article","created":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T22:05:05Z","timestamp":1763330705000},"page":"115830","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"P1","title":["Tumor-derived C4BPA promotes macrophage M2-like polarization through C5a -C5aR1-STAT3 axis and drives gastric cancer progression"],"prefix":"10.1016","volume":"168","author":[{"given":"Zhechuan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keqi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minli","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2025.115830_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101404","article-title":"The current and future incidence and mortality of gastric cancer in 185 countries, 2020-40: a population-based modelling study","volume":"47","author":"Morgan","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.intimp.2025.115830_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.690037","article-title":"M2 macrophage-based prognostic nomogram for gastric Cancer after surgical resection","volume":"11","author":"Hu","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.intimp.2025.115830_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2025.101950","article-title":"Complement and the hallmarks of cancer","volume":"78","author":"Artero","year":"2025","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.intimp.2025.115830_bb0020","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41581-023-00704-1","article-title":"Complosome - the intracellular complement system","volume":"19","author":"West","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.intimp.2025.115830_bb0025","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nri.2017.97","article-title":"Complement in cancer: untangling an intricate relationship","volume":"18","author":"Reis","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2025.115830_bb0030","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/ni.1655","article-title":"Modulation of the antitumor immune response by complement","volume":"9","author":"Markiewski","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2025.115830_bb0035","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/imr.13135","article-title":"Intracellular complement: Evidence, definitions, controversies, and solutions","volume":"313","author":"King","year":"2023","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2025.115830_bb0040","doi-asserted-by":"crossref","first-page":"752","DOI":"10.3389\/fimmu.2019.00752","article-title":"Complement C5b-9 and Cancer: mechanisms of cell damage, Cancer Counteractions, and Approaches for Intervention","volume":"10","author":"Fishelson","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.intimp.2025.115830_bb0045","doi-asserted-by":"crossref","first-page":"5991","DOI":"10.4049\/jimmunol.178.9.5991","article-title":"Down-regulation of human complement factor H sensitizes non-small cell lung cancer cells to complement attack and reduces in vivo tumor growth","volume":"178","author":"Ajona","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2025.115830_bb0050","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.stemcr.2016.11.008","article-title":"CD59 regulation by SOX2 is required for epithelial Cancer stem cells to evade complement surveillance","volume":"8","author":"Chen","year":"2017","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.intimp.2025.115830_bb0055","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0002-9440(10)65626-X","article-title":"Complement-mediated killing of microtumors in vitro","volume":"153","author":"Hakulinen","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.intimp.2025.115830_bb0060","doi-asserted-by":"crossref","first-page":"935","DOI":"10.4049\/jimmunol.167.2.935","article-title":"Regulation of complement classical pathway by association of C4b-binding protein to the surfaces of SK-OV-3 and Caov-3 ovarian adenocarcinoma cells","volume":"167","author":"Holmberg","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2025.115830_bb0065","doi-asserted-by":"crossref","first-page":"14927","DOI":"10.1074\/jbc.M115.708446","article-title":"Complement membrane attack and tumorigenesis: a SYSTEMS BIOLOGY APPROACH","volume":"291","author":"Towner","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2025.115830_bb0070","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.jmb.2012.12.017","article-title":"Arranged sevenfold: structural insights into the C-terminal oligomerization domain of human C4b-binding protein","volume":"425","author":"Hofmeyer","year":"2013","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.intimp.2025.115830_bb0075","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/bjc.2016.295","article-title":"Identification of a novel serum biomarker for pancreatic cancer, C4b-binding protein \u03b1-chain (C4BPA) by quantitative proteomic analysis using tandem mass tags","volume":"115","author":"Sogawa","year":"2016","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.intimp.2025.115830_bb0080","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/eji.200737722","article-title":"Cellular uptake of C4b-binding protein is mediated by heparan sulfate proteoglycans and CD91\/LDL receptor-related protein","volume":"38","author":"Spijkers","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2025.115830_bb0085","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jprot.2011.01.011","article-title":"A high-quality secretome of A549 cells aided the discovery of C4b-binding protein as a novel serum biomarker for non-small cell lung cancer","volume":"74","author":"Luo","year":"2011","journal-title":"J. Proteomics"},{"key":"10.1016\/j.intimp.2025.115830_bb0090","doi-asserted-by":"crossref","first-page":"5062","DOI":"10.1016\/j.cell.2025.07.004","article-title":"Cancer immunology data engine reveals secreted AOAH as a potential immunotherapy","volume":"188","author":"Gong","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2025.115830_bb0095","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s12935-019-1027-3","article-title":"Role of the complement system in the tumor microenvironment","volume":"19","author":"Zhang","year":"2019","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.intimp.2025.115830_bb0100","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.semcdb.2017.11.023","article-title":"Complement anaphylatoxins C3a and C5a: emerging roles in cancer progression and treatment","volume":"85","author":"Ajona","year":"2019","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.intimp.2025.115830_bb0105","article-title":"Integrative analysis of complement system to prognosis and immune infiltrating in Colon Cancer and gastric Cancer","volume":"10","author":"Bao","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.intimp.2025.115830_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.931273","article-title":"Inside-out of complement in Cancer","volume":"13","author":"Kolev","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115830_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.883743","article-title":"The hidden side of complement regulator C4BP: dissection and evaluation of its immunomodulatory activity","volume":"13","author":"Serrano","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115830_bb0120","article-title":"STAT3 pathway in gastric Cancer: Signaling, therapeutic targeting and future prospects","volume":"9","author":"Ashrafizadeh","year":"2020","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.intimp.2025.115830_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095993","article-title":"Inhibition of the JAK2\/STAT3 pathway reduces gastric cancer growth in vitro and in vivo","volume":"9","author":"Judd","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.intimp.2025.115830_bb0130","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.2147\/JIR.S353489","article-title":"Role of JAK2\/STAT3 Signaling pathway in the tumorigenesis, chemotherapy resistance, and treatment of solid Tumors: a systemic review","volume":"15","author":"Mengie Ayele","year":"2022","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.intimp.2025.115830_bb0135","first-page":"5671","article-title":"Constitutive activation of STAT3 and cyclin D1 overexpression contribute to proliferation, migration and invasion in gastric cancer cells","volume":"9","author":"Luo","year":"2017","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.intimp.2025.115830_bb0140","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1038\/sj.onc.1207606","article-title":"STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells","volume":"23","author":"Kanda","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.intimp.2025.115830_bb0145","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1007\/s00262-017-2052-5","article-title":"Interleukin 6 induces M2 macrophage differentiation by STAT3 activation that correlates with gastric cancer progression","volume":"66","author":"Fu","year":"2017","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.intimp.2025.115830_bb0150","doi-asserted-by":"crossref","DOI":"10.4028\/b-wjQRP6","article-title":"M2 tumor-associated macrophages-derived Exosomal MALAT1 promotes glycolysis and gastric Cancer progression","volume":"11","author":"Wang","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.intimp.2025.115830_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215900","article-title":"The complement system as a regulator of tumor-promoting activities mediated by myeloid-derived suppressor cells","volume":"549","author":"Senent","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.intimp.2025.115830_bb0160","doi-asserted-by":"crossref","unstructured":"C. de Freitas Oliveira-Tore, A.G. de Moraes, H. Pl\u00e1cido, N. Signorini, P.D. Fontana, T. da Piedade Batista Godoy, A.B.W. Boldt, I. de Messias, Non-canonical extracellular complement pathways and the complosome paradigm in cancer: a scoping review, Front. Immunol., 16 (2025) 1519465.","DOI":"10.3389\/fimmu.2025.1519465"},{"key":"10.1016\/j.intimp.2025.115830_bb0165","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12929-015-0151-1","article-title":"Complement and macrophage crosstalk during process of angiogenesis in tumor progression","volume":"22","author":"Khan","year":"2015","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.intimp.2025.115830_bb0170","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.3389\/fimmu.2019.01074","article-title":"The role of membrane bound complement regulatory proteins in tumor development and Cancer immunotherapy","volume":"10","author":"Geller","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115830_bb0175","article-title":"The complement system as a target in cancer immunotherapy","volume":"54","author":"Merle","year":"2024","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2025.115830_bb0180","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.1182\/blood-2009-10-249532","article-title":"Complement in antibody therapy: friend or foe?","volume":"114","author":"Introna","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2025.115830_bb0185","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1172\/JCI90962","article-title":"The role of the complement system in cancer","volume":"127","author":"Afshar-Kharghan","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2025.115830_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13061209","article-title":"Complement in Tumourigenesis and the response to Cancer therapy","volume":"13","author":"O\u2019Brien","year":"2021","journal-title":"Cancers (Basel)"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925018181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925018181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T19:41:17Z","timestamp":1781898077000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925018181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":38,"alternative-id":["S1567576925018181"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115830","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor-derived C4BPA promotes macrophage M2-like polarization through C5a -C5aR1-STAT3 axis and drives gastric cancer progression","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115830","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115830"}}